Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 88 citing articles:

Recent advances in CAR-T cell engineering
Ruihao Huang, Xiaoping Li, Yundi He, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 300
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
Chong-xian Pan, Hongtao Liu, Elizabeth Robins, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 215
BCMA-targeted immunotherapy for multiple myeloma
Bo Yu, Tianbo Jiang, Delong Liu
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 166
Targeting Akt in cancer for precision therapy
Hui Hua, Hongying Zhang, Jingzhu Chen, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 165
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Bianca Santomasso, Loretta J. Nastoupil, Sherry Adkins, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 35, pp. 3978-3992
Open Access | Times Cited: 118
Microfluidic tumor-on-a-chip model to evaluate the role of tumor environmental stress on NK cell exhaustion
José M. Ayuso, Shujah Rehman, Marı́a Virumbrales-Muñoz, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 116
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 86
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 60
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Expression patterns of immune checkpoints in acute myeloid leukemia
Cunte Chen, Chaofeng Liang, Shunqing Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 133
Emerging agents and regimens for hepatocellular carcinoma
Xiao‐Dong Zhu, Hui‐Chuan Sun
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 93
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes
Jie Liu, Shuo Yang, Bihui Cao, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 74
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer
Hajar Alemohammad, Basira Najafzadeh, Zahra Asadzadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112516-112516
Open Access | Times Cited: 71
Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
Peipei Wang, Yueyun Chen, Qingqin Long, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e002836-e002836
Open Access | Times Cited: 65
CAR‐T cell therapy for lung cancer: Potential and perspective
Long Chen, Fukun Chen, Jindan Li, et al.
Thoracic Cancer (2022) Vol. 13, Iss. 7, pp. 889-899
Open Access | Times Cited: 49
Car T Cells in Solid Tumors: Overcoming Obstacles
Joselyn Rojas, María P. Díaz, Jim Palmar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4170-4170
Open Access | Times Cited: 13
Therapeutic synthetic and natural materials for immunoengineering
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
CAR-T cells: Early successes in blood cancer and challenges in solid tumors
Hassan Dana, Ghanbar Mahmoodi Chalbatani, Seyed Amir Jalali, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 5, pp. 1129-1147
Open Access | Times Cited: 70
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies
Yuru Nie, Weiqing Lu, Daiyu Chen, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 69
“Trojan Horse” Salmonella Enabling Tumor Homing of Silver Nanoparticles via Neutrophil Infiltration for Synergistic Tumor Therapy and Enhanced Biosafety
Ze Mi, Lina Guo, Peng Liu, et al.
Nano Letters (2020) Vol. 21, Iss. 1, pp. 414-423
Closed Access | Times Cited: 66
CAR T-cell therapy for triple-negative breast cancer: Where we are
Yuetao Xie, Yi Hu, Nawu Zhou, et al.
Cancer Letters (2020) Vol. 491, pp. 121-131
Closed Access | Times Cited: 64
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
Xiaoya Yun, Ya Zhang, Xin Wang
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics
Dia Advani, Sudhanshu Sharma, Smita Kumari, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 433-468
Closed Access | Times Cited: 48
Mechanisms of CAR T cell exhaustion and current counteraction strategies
Xiaoying Zhu, Qing Li, Xiaojian Zhu
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 33
Exploring potential of exosomes drug delivery system in the treatment of cancer: Advances and prospective
Deepika Yadav, Rishabha Malviya
Medicine in Drug Discovery (2023) Vol. 20, pp. 100163-100163
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top